Glycated hemoglobin standardization--National Glycohemoglobin Standardization Program (NGSP) perspective
- PMID: 14598869
- DOI: 10.1515/CCLM.2003.183
Glycated hemoglobin standardization--National Glycohemoglobin Standardization Program (NGSP) perspective
Abstract
The Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS) demonstrated conclusively that risks for complications in patients with diabetes are directly related to glycemic control, as measured by glycated hemoglobin (GHb). Many diabetes organizations worldwide now recommend GHb _targets in terms of DCCT/ UKPDS hemoglobin A1c (HbA1c). However, in 1993 there was a lack of comparability of GHb test results among methods and laboratories that represented a major obstacle to meaningful implementation of specific guidelines for diabetes care. The National Glycohemoglobin Standardization Program (NGSP) was implemented to enable laboratories to report DCCT/UKPDS-traceable GHb/HbA1c results. The number of methods and laboratories certified by the NGSP as traceable to the DCCT has steadily increased. Proficiency testing results show marked improvement in the comparability of GHb results. By the end of 2002, 98% of surveyed laboratories (n = approx. 2000) reported GHb results as HbA1c or equivalent compared to 50% in 1993. Ninety-seven percent of laboratories used an NGSP-certified method. For most certified methods in 2002, between-laboratory CVs were < 5%. For all certified methods in 2002, the mean HbA1c value (%) was within 0.8% HbA1c from the NGSP _target at all HbA1c concentrations. The vast majority of laboratories in the US are now reporting results that are traceable to DCCT/UKPDS outcomes.
Similar articles
-
The national glycohemoglobin standardization program: a five-year progress report.Clin Chem. 2001 Nov;47(11):1985-92. Clin Chem. 2001. PMID: 11673367
-
Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care.Clin Chem. 2011 Feb;57(2):205-14. doi: 10.1373/clinchem.2010.148841. Epub 2010 Dec 9. Clin Chem. 2011. PMID: 21148304 Review.
-
The long and winding road to optimal HbA1c measurement.Clin Chim Acta. 2013 Mar 15;418:63-71. doi: 10.1016/j.cca.2012.12.026. Epub 2013 Jan 11. Clin Chim Acta. 2013. PMID: 23318564 Free PMC article. Review.
-
Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: Comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories.Ann Clin Biochem. 2005 Jan;42(Pt 1):41-6. doi: 10.1258/0004563053026835. Ann Clin Biochem. 2005. PMID: 15802031
-
Haemoglobin A1c--a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS).Clin Chem Lab Med. 2003 Sep;41(9):1182-90. doi: 10.1515/CCLM.2003.182. Clin Chem Lab Med. 2003. PMID: 14598868 Review.
Cited by
-
Effect of switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL (Gla-300) in Brazilian people with type 1 diabetes.Diabetol Metab Syndr. 2024 Jul 9;16(1):152. doi: 10.1186/s13098-024-01385-x. Diabetol Metab Syndr. 2024. PMID: 38982528 Free PMC article.
-
Impact of Glycemic Control on Shoulder Proprioception in Type 2 Diabetes Mellitus: Mediating the Connection - Insights from a Cross-Sectional Analysis.J Multidiscip Healthc. 2024 Jul 1;17:3043-3052. doi: 10.2147/JMDH.S468359. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 38974374 Free PMC article.
-
Influence of Phenotypes on the Metabolic Syndrome of Women with Polycystic Ovary Syndrome over a Six-Year Follow-Up in Brazil.Biomedicines. 2023 Dec 9;11(12):3262. doi: 10.3390/biomedicines11123262. Biomedicines. 2023. PMID: 38137483 Free PMC article.
-
Clinical Risk Assessment and Comparison of Bias between Laboratory Methods for Estimation of HbA1c for Glycated Hemoglobin in Hyperglycemic Patients.Curr Diabetes Rev. 2024;20(7):e261023222764. doi: 10.2174/0115733998257140231011102518. Curr Diabetes Rev. 2024. PMID: 37921160
-
Is the Current Cut Point for Glycated Haemoglobin (HbA1c) Correct for Diagnosing Diabetes Mellitus in Premenopausal Women? Evidence to Inform Discussion.Diabetes Ther. 2024 Jan;15(1):99-110. doi: 10.1007/s13300-023-01482-6. Epub 2023 Sep 30. Diabetes Ther. 2024. PMID: 37777677 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical